Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology on contemporary arts and culture.

After months of merchant frustration over securing the required API key for website-reported local inventory feeds via Google Tag Manager, Google has now confirmed a straightforward process: Why we ...

In Microsoft Office, a SmartArt graphic ranges from the graphical list and process diagrams to more complex graphics such as Venn diagrams and Organization charts. SmartArt is visually used to ...

The latest generative AI models are not just stand-alone text-generating chatbots—instead, they can easily be hooked up to your data to give personalized answers to your questions. OpenAI’s ChatGPT ...

Process intelligence vendor Celonis' new Chief Customer Officer Dilipkumar Khandelwal argues that enterprises should focus on using AI to generate new revenue streams and business models rather than ...

OpenAI is now fighting a court order to preserve all ChatGPT user logs—including deleted chats and sensitive chats logged through its API business offering—after news organizations suing over ...

The company is the latest AI vendor to launch an API to help developers embed its AI in their software. Analyst calls it a ‘parity play.’ Artificial intelligence startup Mistral AI Tuesday announced ...

Later this year, companies will get a chance to get their hands on Zenda, an Saas that is poised to redefine operational planning and management. MD+DI spoke with Harold Hambrose - Chief Strategy ...

OpenAI may soon require organizations to complete an ID verification process in order to access certain future AI models, according to a support page published to the company’s website last week. The ...

Visio in Microsoft 365 is a superb tool for creating custom diagrams to illustrate concepts that are difficult to explain through text. Here’s how to use it. It’s often much easier to convey ...

The pharmaceutical services provider Sterling Pharma Solutions will produce hypericin, the active ingredient in an oncology drug being developed by the biotech firm Soligenix. Sterling says it will ...